PENG vs. FIC Block for Hip Fracture ED Patients
NCT05102760
Femoral Fractures, Fractures, Bone
Brooklyn, New York, United States
View Trial DetailsNCT Number: NCT00703716
The purpose of this study is to evaluate the stabilization of trochanteric fracture using a screw-plate TRAUMAX
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Hôpital d'Instruction des Armées R. Picqué, Bordeaux, France
Hip fractures are a serious public health problem. The current incidence is projected to increase fourfold worldwide by the year 2050. This affliction is obviously linked to the aging of the population and the absence of a systematic prevention of osteoporosis.
This leads to the creation of a minimally invasive, or ever percutaneous, implantable osteosynthesis material which associates :
The TRAUMAX answers to all those characteristics.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months after surgery
Time frame: 6 months after surgery
Time frame: 3 and 6 months after surgery
Time frame: 3 and 6 months after surgery
Time frame: during the surgery
Time frame: during the surgery
Time frame: 5 days, 3 and 6 months
Looking for future studies?
Notify MeIntegra LifeSciences Services
Industry
Acronym: TRAUMAX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05102760
Femoral Fractures, Fractures, Bone
Brooklyn, New York, United States
View Trial DetailsNCT07639762
Agnosia, Femoral Fractures
Istanbul, Sancaktepe, Turkey (Türkiye)
View Trial DetailsNCT07400770
Agnosia, Anxiety Disorders
Taizhou, Jiangsu, China
View Trial DetailsNCT07124247
Brain Diseases, Cardiovascular Diseases
Pellenberg, Belgium
View Trial Details